Targeting caspase-8/c-FLIPL heterodimer with small molecule FLIPinB in combination with death ligands, gemcitabine and Mcl-1 inhibitor efficiently eliminates pancreatic cancer cells via promoting complex II assembly. This evidence concerns the gene CFLAR and familial pancreatic carcinoma.